You are here
Peer-Reviewed Articles selected by Lymphoma resource centre editors Francesco Bertoni, MD and Anastasios Stathis, MD.
All journal papers are available in full text format with PDFs of the complete papers.
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trialThe Lancet Oncology, Volume 15, Issue 1, January 2014, Pages 69–77
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialThe Lancet Oncology, Early Online Publication, 4 March 2014